Marksans Pharma has informed that a meeting of the Board of Directors of the Company will be held on November 12, 2016, to consider and approve Unaudited Financial Results of the Company (both Standalone and Consolidated) for the Second Quarter ended on September 30, 2016 (Q2). Further, as per the Insider Trading Policy of the Company, Trading Window for dealing in Company’s shares will remain closed for the Company’s Insiders from November 04, 2016 (commencing from the time of above intimation to the Stock Exchanges) till 48 hours after the announcement of the second quarter financial results on November 12, 2016.
The above information is a part of company’s filings submitted to BSE.
